Management of Essential Hypertension

Area of Science:

• Cardiology
• Public Health
• Pharmacology

Background:

• Essential hypertension significantly contributes to cardiovascular morbidity and mortality.
• Hypertension prevalence and control vary across racial/ethnic groups in the US, with African Americans experiencing the highest prevalence and least control.
• While lifestyle modifications are foundational, most patients require pharmacotherapy, often combination therapy.

Purpose of the Study:

• To summarize current recommendations for the pharmacologic treatment of essential hypertension.
• To highlight disparities in hypertension prevalence and control among different racial/ethnic groups.
• To outline the principal drug classes recommended for initial hypertension management.

Main Methods:

• Review of current clinical guidelines and literature on essential hypertension treatment.
• Analysis of epidemiological data regarding hypertension prevalence and control by race/ethnicity.
• Synthesis of evidence supporting first-line pharmacologic interventions.

Main Results:

• Essential hypertension treatment is vital for cardiovascular risk reduction.
• Significant racial/ethnic disparities exist in hypertension prevalence and control within the US.
• Thiazide-type diuretics, calcium channel blockers, and ACE inhibitors/ARBs are recommended as initial pharmacotherapy.

Conclusions:

• Effective management of essential hypertension is critical for public health.
• Addressing racial/ethnic disparities in hypertension control is a priority.
• Specific drug classes form the cornerstone of initial pharmacotherapy for essential hypertension.